CLABF - Core One Labs acquires Awakened Biosciences

Core One Labs (OTCPK:CLABF) completed the acquisition of all the outstanding share capital of psychedelics research and technology company Awakened Biosciences. Core One issued 7.03M common shares and ~1.46M share purchase warrants entitling the holders to acquire an equivalent number of common shares of the company at a price of $1.15/share until Feb. 4, 2024. Core One said Awakened has developed novel technologies for the production of synthetic psilocybin, and for the manufacturing of various no-psychoactive psilocybin-based prodrugs. Awakened’s production methods have resulted in the filing of three provisional patents applications with the U.S. Patent and Trademark Office. The transaction also increases the company’s catalogue of psychedelic compounds available for clinical and medicinal research.

For further details see:

Core One Labs acquires Awakened Biosciences